• Title of article

    A Rare Case of Fixed Drug Eruption due to Ondansetron

  • Author/Authors

    Tripathi, Santanu Kumar Department of Clinical and Experimental Pharmacology - Calcutta School of Tropical Medicine, Kolkata, India , Paik, Sabyasachi Department of Clinical and Experimental Pharmacology - Calcutta School of Tropical Medicine, Kolkata, India , Maitra, Aditi Department of Clinical and Experimental Pharmacology - Calcutta School of Tropical Medicine, Kolkata, India , Bhattacharyya, Shashwat Department of Ophthalmology - Calcutta National Medical College, Kolkata, India , Pathak, Prerna Department of Dermatology and Venereology - Calcutta School of Tropical Medicine, Kolkata, India

  • Pages
    4
  • From page
    497
  • To page
    500
  • Abstract
    Fixed drug eruption (FDE) is a unique type of cutaneous drug reaction that typically recurs in the identical locations on re-exposure to the attributed drug. FDE is characterized by the appearance of a single or multiple sharply demarcated violaceous erythematous plaques which heal with residual hyperpigmentation. A 27-year-old woman presented with multiple dark patches over her eyelids, mouth, lips, and shoulders of 1 week’s duration. These lesions followed multiple erythematous plaques over the same areas which appeared within 4 hours of the intake of an ondansetron tablet, 12 days previously. The case was diagnosed as post-inflammatory hyperpigmentation following ondansetroninduced FDE. There was an identical episode 1 year earlier due to the intake of the same drug. The causality assessment pointed toward a probable/likely association as per the Naranjo algorithm and the WHO–UMC scale. There have been only a few cases of FDE due to ondansetron in the reported literature.
  • Keywords
    Ondansetron , Hyperpigmentation , Fixed drug eruption , 5HT3 receptor antagonists
  • Journal title
    Astroparticle Physics
  • Serial Year
    2017
  • Record number

    2445339